Location out of bounds
Lab technicians performing tests

Factor VIII Chromogenic

Improved Factor VIII monitoring for Hemophilia A patients receiving emicizumab-kxwh.

Available Summer 2019

Client Services

Email 800-245-3117 x 6250 Online Ordering Portal Hemostasis Requisition

Your diagnostic partner in Hemophilia

Versiti’s Factor VIII Chromogenic Assay (all-bovine reagent) is recommended for measuring endogenous or infused factor VIII activity and inhibitors, including the monitoring of patients with hemophilia A receiving emicizumab-kxwh.

Available Summer 2019

Advantages of Versiti's Factor VIII Chromogenic Assay:

Versiti’s Factor VIII Chromogenic Activity (all-bovine reagent) is can be used in the diagnosis of nonsevere hemophilia A, and useful in the accurate determination of factor VIII (FVIII) activity in the presence of a lupus anticoagulant or when certain modified recombinant FVIII replacement products are present, such as domain deleted Factor VIII formulations.

More about Hemophilia A:

Hemophilia A is an X-linked inherited bleeding disorder caused by mutation of the factor VIII (FVIII) gene that encodes for coagulation factor VIII. The degree of plasma factor deficiency correlates with both the clinical severity of disease and genetic findings. 


This website uses cookies to ensure you get the best experience on our website. Learn more